In another case-control study, the level of transferrin was measured using an immunological turbidimetric assay in the sera of 37 women with ovarian cancer and compared to those with benign ovarian diseases (N = 31) and age–matched healthy controls (N = 31). Here, TF is linked to ovarian cancer.